Your session is about to expire
← Back to Search
Reducing Unnecessary Care for Traumatic Injury
N/A
Waitlist Available
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18-month interval (6 to 24 months) after implementation
Awards & highlights
Study Summary
This trial will study how to reduce unnecessary tests & procedures in injury admissions, leading to improved healthcare efficiency, cost savings & reduced adverse events.
Who is the study for?
This trial is for adult trauma centers in Québec's Trauma Care Continuum, specifically levels I-III. It aims to improve care for patients hospitalized with injuries by reducing unnecessary medical procedures. Level IV centers are excluded due to low patient volumes.Check my eligibility
What is being tested?
The study tests two approaches to reduce low-value clinical practices: usual practice with simple audit & feedback versus enhanced audit & feedback combined with educational outreach and facilitation. The goal is to see which method better reduces unnecessary tests and treatments.See study design
What are the potential side effects?
Since this trial focuses on process improvement rather than direct patient interventions, it does not involve medications or treatments that would typically have side effects. However, changes in care processes could potentially impact patient experiences.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18-month interval (6 to 24 months) after implementation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18-month interval (6 to 24 months) after implementation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Low-value initial diagnostic imaging
Secondary outcome measures
Low-value specialist consultation
Pre-transfer imaging
Repeat post-transfer imaging
Other outcome measures
Complications
Hospital stay
Incremental Cost-Effectiveness Ratios
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Simple audit & feedbackExperimental Treatment1 Intervention
The control arm will receive the quality improvement intervention currently in place in the Québec Trauma Care Continuum (i.e. simple A&F report presenting their performance compared to peers on quality indicators measuring adherence to high-value care and risk-adjusted outcomes) with the addition of quality indicators on low-value care (already planned by provincial authorities for the 2023 evaluation cycle). Simple A&F was chosen for the control because it is standard practice in Québec and in most integrated trauma systems and the effectiveness of A&F for de-implementation has been documented.
Group II: Audit & feedback with educational outreach and facilitationExperimental Treatment1 Intervention
The intervention includes: 1) refinement with end users, 2) an A&F report sent to local governing authorities presenting for each practice: performance compared to peers (simple A&F), a summary message indicating if action is required and a list of potential actions, 3) educational materials (a clinical vignette; consequences of the practice; links to practice guidelines, clinical decision rules and shared decision-making tools; a case review tool), 4) virtual educational meetings with the local trauma Medical Director, trauma program manager and data analyst, and 5) two virtual facilitation visits 2 and 4 months after the transmission of the report to support committees in preparing their action plan.
Find a Location
Who is running the clinical trial?
Trauma Association of CanadaUNKNOWN
Health Standards OrganisationUNKNOWN
Audit & Feedback MetalabUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Simple audit & feedback
- Group 2: Audit & feedback with educational outreach and facilitation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this study actively seeking participants?
"Clinicaltrials.gov evidence indicates that this trial, which was first published on June 1st 2023 and last updated February 15th 2023, is no longer recruiting participants. Despite this unfortunate reality, there are presently 750 other clinical trials actively seeking patients to take part in the study."
Answered by AI
Share this study with friends
Copy Link
Messenger